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SURGICAL ETHICS CHALLENGES
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A younger vascular surgeon has been recruited to start a new program at a suburban hospital outside of a large city
hosting a world-class medical center. The new program will provide state-of-the-art equipment, including robotics, free
ofﬁce space, and a generous salary guarantee. Dr Ready obtained a license in the state where he is relocating and is
preparing to move. He is an excellent technical surgeon but is uncomfortable with complex aneurysm surgery. This
morning he went to sign a contract with the hospital and found that a clause that prevents him from referring patients to
physicians outside the hospital in strong legalese is included. How should he proceed?A. Do not sign.
B. Sign but plan to make appropriate referrals.
C. Consult his attorney.
D. Consult the hospital’s ethics committee.
E. Sign.“Money doesn’t talk, it swears.”
eBob Dylan (It’s Alright Ma (I’m Only Bleeding))It is past time for physicians to confront the reality that
medicine is a business, not charitable endeavor, and there-
fore must be organized and led in a ﬁscally sound manner.
Medicine as the most complex business model is facing
serious threats to its professional, ﬁduciary commitment.
Politicians, regulators, and administrators are becoming
more intrusive into medical affairs and ever more powerful.
An emerging professional concern should be that, as physi-
cian control in medical practice decreases, quality of care is
at risk for being adversely affected.
American medicine is going to have to cope with an ag-
ing population that has adopted the unhealthiest lifestyle
on the planet as an incubator for chronic disease. Medical
professional dedication and the proﬁt motive have made
enhanced and costlier therapies available. Sade1 identiﬁed
the economic problem: Consumers of health care do not
perceive they are spending their own money. “It is viewed
as a service that has already been prepaid.” And the Afford-
able Care Act is set to provide more unfunded medicalThe Center for Medical Ethics and Health Policy, Baylor College of
edicine.
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Recognition of the need to control the steadily acceler-
ating cost of medical care has been around for more than
three decades, as evidenced by the beginning of managed
care in the early 1980s. Managed care’s objectives were
to reduce cost and ostensibly improve quality; it has a
poor record of accomplishment on both counts.
Engelhardt2 warned more than a decade ago that med-
icine was losing status as “a self-governing guild with its
own moral vision.” He decried that “the good of the pa-
tient has now been qualiﬁed in terms of concerns for pa-
tient autonomy and ﬁnancial constraints.”2
American medicine’s professionalism is ill prepared to
deal with these ﬁnancial problems; it broadly considers
ﬁnances not to be a central factor in medical care decisions.
Generally, as it should be, patient safety is paramount, fol-
lowed closely by the patient’s wishes. Cost has insidiously
grown more important since managed care permeated
medicine, and steadily rising cost is likely to impose future
restrictions that are inconceivable today. This case identiﬁes
how macroeconomic pressures on medical managers from
insurers, who are in turn pressured by government, will
seek to regulate medical decisions of physicians at the orga-
nizational level.
Whether or not restrictions of medical practice are ethi-
cally permissible depend on whether they will prevent the
standard of care to be provided to every patient. Not all clin-
ical pathways are unnecessary intrusions; some promote
quality medicine by standardization and limiting possible
omissions. If such supportive clinical pathways result in
decreased growth in the cost of medical care, physicians
should not object, they should applaud, because professional
responsibility and ﬁscal responsibility will become aligned.1737
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but little to do with policy; it seems to focus on reimburse-
ment. The American Medical Association’s Political Action
Web site is entirely devoted to ﬁnancial data. Their paper,
“Advocating for improvement to the Affordable Care
Act,” lists nine provisions that need to be reﬁned, and
seven are concerned with reimbursement.3 Leading from
behind is a common leadership criticism because it is not
leading at all; it is capitulation.
Just as medicine considers patient safety foremost in
every individual patient’s therapy, it should remain so in so-
cietal policy decisions. Cost is a necessary consideration and
the impetus but should be focused on reducing the cost of
quality medicine. When the national medical care budget is
sustainable, nonmedical pressures to control medical prac-
tice will abate; necessity is their stimulus.
There is a broad solution. Simply put:America cannot afford the accelerating cost of medical
technology to make unhealthy lifestyles less dangerous.
Thus, it is essential that medical leadership, health advo-
cates, and government establish national programs of
health education and incentives to foster healthy lifestyles.
Health is a personal moral responsibility, and unless Amer-
icans take health-promoting lifestyles seriously, we could
become a pauper nation populated with invalids.4The euphemistic “guidance” in this case is actually a
demand. Few in procedural specialties are master artisans
in all procedures, especially newly minted ones. Clinical
integrity demands referring patients to others when it
clearly is in the patient’s best interest. This is necessary as
soon as the patient’s clinical needs exceed one’s skills set.
If Dr Ready has such colleagues in his hospital, there is
no problem with the contractual restriction to which he
has been asked to agree. In a suburban hospital, however,
this is unlikely to be true for all of Dr Ready’s patients.
Economic restrictions are not all bad. Opining that
there are no budgetary restrictions is absurd; it ignores
the law of diminishing returns. The prime example of
over utilization is at end of life. The survival of patients
with unresectable pancreatic cancer is measured in months
regardless of medical therapy. There are aggressive oncolo-
gists who administer therapy costing 100% more than those
less aggressive, and despite the increased cost and
morbidity, survival is the same.5 Oncologists did that study.
Economic restrictions on medical practice, however, that
remove access to indicated therapeutic tools or repress validevidence-based decisions are ethically unacceptable. Signing
on as a double agent (option B) speaks of a defective moral
character and will likely result in future work problems. Op-
tion E undermines professional integrity and is therefore
ruled out. Consulting an attorney on a matter of ethics speaks
of a confused or, worse, weak mind. C is absurd. An ethics
committee in most circumstances has the least political power
in medicine. Consulting them speaks of poor judgment.
Option A is ethically required for Dr Ready to protect
his professional integrity. Dr Ready should start with the
chief medical ofﬁcer and explain that this clause in the
contract is ethically impermissible and should be removed
for all of the physicians at the hospital. The chief medical
ofﬁcer’s professional integrity is now being tested. If he or
she fails the test, he or she will tell Dr Ready that the con-
tract is take-it-or-leave-it. Dr Ready will then learn some-
thing very important: the hospital’s culture is corrupt. He
should run, not walk, to the nearest exit. If the chief med-
ical ofﬁcer is committed to the protection of the profes-
sional integrity of medical staff members, he or she will
take this matter to the chief executive ofﬁcer of the hospi-
tal and demand that physicians employed by the hospital
be able to practice freely without possible quality
restrictions.
When physicians worthy of being called “professional”
detect that money is swearing at professional integrity,
which is just what this contract is doing, they should
promptly swear back and be prepared to dissociate them-
selves from corrupt organizational cultures.
We wish to acknowledge Dr Kathleen Fenton, who
gave us the idea for this case from a piece she submitted
to the Thoracic Surgical Ethics Forum.
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